Table 1.
Population | Bocozel, no. (%) | Grand Saline, no. (%) | Total, no. (%) |
---|---|---|---|
Community coverage | 76.7–92.7%* | 62.5%† | |
Received at least 1 dose | 32,210 (70.9) | 13,207 (29.1) | 45,417 |
Sex | |||
F | 15,799 (49.0) | 6,630 (50.2) | 22,429 (49.4) |
M | 16,383 (50.9) | 6,555 (49.6) | 22,938 (50.5) |
Age, years | |||
1–4 | 3,630 (11.3) | 1,268 (9.6) | 4,898 (10.8) |
5–9 | 3,887 (12.1) | 1,792 (13.6) | 5,679 (12.5) |
10–17 | 5,744 (17.8) | 2,505 (19.0) | 8,249 (18.2) |
≥ 18 | 18,921 (58.7) | 7,620 (57.7) | 26,541 (58.4) |
Completion rate | |||
Received 2 doses | 29,204 (90.7) | 12,038 (91.1) | 41,242 (90.8) |
Sex | |||
F | 14,426 (91.3) | 6,147 (92.7) | 20,573 (91.7) |
M | 14,752 (90.0) | 5,869 (89.5) | 20,621 (89.9) |
Age, years | |||
1–4 | 3,400 (93.7) | 1,188 (93.7) | 4,588 (93.7) |
5–9 | 3,665 (94.3) | 1,697 (94.7) | 5,362 (94.4) |
10–17 | 5,217 (90.8) | 2,268 (90.5) | 7,485 (90.7) |
≥ 18 | 16,895 (89.3) | 6,863 (90.1) | 23,758 (89.5) |
Lower limit was calculated by census data, and upper limit was calculated by post-campaign coverage survey.
Calculated using government demographic data.